Watch The Recording Now:
Oncological Wound Mangement Mini-Series
On Thursday 4th May we hosted an interactive and engaging livestream event covering the challenges of oncological surgery and wound management strategies and impact of the patient, with guest speakers Jon Hall MA VetMB CertSAS DipECVS SFHEA FRCVS and Georgie Hollis BSc of Vet Wound Library.
Oncological surgery requires good knowledge and technique to achieve the best outcomes for surgical patients. Watch now as RCVS & European Specialist in Veterinary Surgery, Professor Jon Hall, discusses how best to approach these tricky cases and how to manage those more challenging sites. Following this, wound expert Georgie Hollis talks us through managing open wounds, plus how this can impact both patient and owner.
Finally, Neil Mottram BSc BVSc MRCVS from Virbac discusses the latest intratumoural injection, Stelfonta ®. This session starts with a 'how to' section, followed by case studies to show attendees that 'seeing is believing'.
WATCH NOW - CLICK PLAY ON THE VIDEO ABOVE
About the expert speakers:
Jon Hall
Jon comes from a veterinary family and spent several years in general practice. He's worked at the RVC, Cambridge and Edinburgh vet schools as a clinical academic and is now a Professor of Small Animal Surgery at Nottingham.
The majority of his clinical work is at Wear Referrals and he is active in postgraduate qualification training and examining.
Georgie Hollis
Georgie is the founder of the Vet Wound Library and the Bandaging Angels. Specialising in wound technologies, Georgie has a passion for researching the latest in wound care and their potential role in the Veterinary patient.
Georgie has over 15 years experience in the Veterinary field, regularly presenting on the subject of wound management and dressing selection.
Neil Mottram
Neil qualified from the University of Liverpool in 2013. After a year in mixed practice he moved to Devon to focus on small animal practice.
Neil now works for Virbac and heads STELFONTA - the latest intratumoural treatment for canine mast cell tumours.
Virbac Stelfonta
STELFONTA® is an innovative and effective intratumoural treatment for mast cell tumours - the most common cutaneous neoplasm in dogs. It's active ingredient, Tigilanol tiglate, has a unique mode of action causing destruction of the mast cell tumour and there is complete resolution in 75% of cases after just one treatment. Treatment results in complete tumour destruction, leaving behind a healthy granulating wound which heals by secondary intention with minimal intervention within just 4-6 weeks.
